Section 5: Patient Safety and Quality Assurance

5PSQ-152

DO WE KNOW THE CONTENT OF HARMFUL EXCIPIENTS IN MEDICINES THAT NEONATES RECEIVE?

5PSQ-151

ARE PROPOFOL EMULSIONS STABLE WHEN INTRAVENOUSLY CO-ADMINISTERED WITH REMIFENTANIL?

5PSQ-150

TRADITIONAL MISUSE OF CAMPHOR POWDER: CONCERNING TWO CASES OF PAEDIATRIC POISONING

5PSQ-149

SELF-MEDICATION IN CANCER PATIENTS: SURVEY CONDUCTED IN THE PHARMACY DEPARTMENT OF A UNIVERSITY HOSPITAL

5PSQ-148

PHARMACOVIGILANCE AND CLINICAL PHARMACY APPLIED TO MEDICAL DEVICES: SHOULD CANCER PATIENTS BE INFORMED ABOUT THEIR MEDICAL DEVICES?

5PSQ-147

THE VALSARTAN SAGA: PHARMACISTS' COMPETENCE TO RESOLVE THE THERAPEUTIC CHALLENGE

5PSQ-146

DRUGS INTERACTION ANALYSIS OF PRESCRIPTIONS OF A TEACHING HOSPITAL: FREQUENCY AND GRAVITY

5PSQ-145

SEVERITY OF MEDICATION RECONCILIATION ERRORS IN ELDERLY PATIENTS PRODUCED IN THE EMERGENCY DEPARTMENT

5PSQ-144

MEDICATION RECONCILIATION PROGRAMME PERFORMED IN A GENERAL AND DIGESTIVE SURGERY SERVICE

5PSQ-143

PREVALENCE OF POTENTIALLY INAPPROPRIATE PRESCRIPTIONS IN INSTITUTIONALISED AND NON-INSTITUTIONALISED ELDERLY PATIENTS

5PSQ-142

RISK FACTORS FOR HYPONATRAEMIA IN ELDERLY PATIENTS, BEYOND PHARMACOLOGICAL ADVERSE EFFECTS

5PSQ-141

POLYPHARMACY AND TRANSCATHETER AORTIC VALVE IMPLANTATION

5PSQ-140

THE COMMUNICATION PROCESS BETWEEN PHARMACY AND OTHER DEPARTMENTS AND WARDS IN AN ACUTE HOSPITAL

5PSQ-139

ORTHOPAEDIC IMPLANT RESUPPLY CHAIN: BETTER, FASTER, STRONGER!

5PSQ-138

REVIEW OF MEDICATION ERRORS IN A PAEDIATRIC HOSPITAL BASED ON AN INSTITUTIONAL REPORTING SYSTEM

Pages